07.09.2021 • NewsInvista

Invista Beefing up PA Output in Shanghai

Invista Nylon Chemicals (China), subsidiary of Wichita, Kansas-based US polyamide giant Invista, has announced a major expansion of its PA 6.6 capacity in China’s Shanghai Chemical Industry Park (SCIP), which It said will strengthen its integrated production chain in the People’s Republic.

The company’s Chinese arm plans to invest $ 230 million in two production lines at the Shanghai site, thereby more than doubling its output capability from currently 190,000 t/y to 400,000 t/y. Some 40,000 t/y of new capacity was added in late 2020. Work on the massive expansion is due to begin at the beginning of 2022, with start-up planned for spring 2024.

Invista’s latest investment in the chemical park goes hand-in-hand with an upstream project that calls for adding 400,000 t/ of adiponitrile (ADN) capability) by the beginning of 2021. This new facility will feed the site’s 215,000 t/y production of nylon intermediate hexamethylenediamine (HMD).

Supporting the buildup, Invista said, is the projected compounded annual growth rate of 4% in Chinese demand for PA 6.6 – about twice that forecast for the market globally. The company noted also that the enhanced capacity will allow it to more quickly respond to growing demand in its Asian main markets of engineering plastics and apparel.

The world’s largest producer of polyamide, which owns the rights to the Nylon trademark, calculates additionally that Chinese demand for PA products will account for more than half the total production and consumption n in the Asia-Pacific region altogether.

Author: Dede Williams, Freelance Journalist

 

In a move to strengthen its integrated production chain, US nylon giant Invista...
In a move to strengthen its integrated production chain, US nylon giant Invista is investing $230 million in two new PA 6.6 production lines its Shanghai, China, site, more than doubling capacity from 190,000 t/y to 400,000 t/y. The expansion is due on stream in spring 2024. (c) Invista

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.